Condition
Rod Cone Dystrophy clinical trials and research
As of November 12, 2026, Find a Trial lists 6 Rod Cone Dystrophy clinical trials that are recruiting, at sites in 5 countries (most in United States (3), Belgium (2), France (2)). By phase: Phase 1/2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 5Countries
Newest Rod Cone Dystrophy clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Natural History Look at Advanced Rod-Cone Dystrophy under Standard Care | — | Ghent and 2 other locations | Recruiting | Oct 2, 2026 |
| Gene therapy SPVN20 for advanced rod-cone dystrophy | Phase 1/2 | Ghent and 2 other locations | Recruiting | Sep 8, 2026 |
| Brain stimulation to improve orientation and mobility in adults with vision impairment | — | Waterloo, Ontario | Recruiting | Jan 14, 2026 |
| Investigating OpCT-001 for treating primary photoreceptor disease | Phase 1/2 | Los Angeles, California and 4 other locations | Recruiting | Jan 23, 2025 |
| Imaging of outer retinal diseases using adaptive optics | — | Bethesda, Maryland and 1 other locations | Recruiting | May 2, 2022 |
| Registry for inherited retinal degenerative diseases | — | Columbia, Maryland | Recruiting | May 6, 2015 |
All recruiting trials (6)
-
Natural History Look at Advanced Rod-Cone Dystrophy under Standard Care
This study tests how standard eye care affects people with advanced rod-cone dystrophy (retinitis pigmentosa) to understand what happens over time.
-
Gene therapy SPVN20 for advanced rod-cone dystrophy
This study tests different doses of SPVN20 injected into the eye to see if it is safe and can help people with advanced rod-cone dystrophy.
-
Brain stimulation to improve orientation and mobility in adults with vision impairment
This pilot test checks if a non-invasive brain stimulation method can help people with constricted visual fields move around more easily using a cane and other cues.
-
Investigating OpCT-001 for treating primary photoreceptor disease
This study is testing a new treatment called OpCT-001 to see if it can safely help adults with primary photoreceptor diseases, like Retinitis Pigmentosa and Usher Syndrome, improve their vision.
-
Imaging of outer retinal diseases using adaptive optics
This study is trying to take detailed pictures of the retina in people with outer retinal diseases to help find better ways to diagnose and understand these conditions.
-
Registry for inherited retinal degenerative diseases
This study is creating a registry for people with rare inherited eye diseases to help track their health and experiences over time, making it easier to understand these conditions and support research.
Related topics
Quick answers
How many Rod Cone Dystrophy clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in United States (3 trials), Belgium (2 trials), France (2 trials), Ireland (2 trials), Canada (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.